Kim Christopher
CIK 0002040022
Chairman and CMODirector
Filings
3
Latest Oct 17, 2025
Issuers covered
1
Showing
3 of 3
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +2.1% | +2.1% | +5.7% | -1.6% |
| 90 days | 2 | 0% | -13.0% | -13.0% | -12.6% | -13.4% |
| 180 days | 2 | 100% | +48.9% | +48.9% | +53.5% | +44.4% |
| 365 days | 2 | 0% | -92.6% | -92.6% | -92.6% | -92.6% |
Issuers
Companies where Kim Christopher has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| APUS | Apimeds Pharmaceuticals US, Inc. | 3 | Oct 17, 2025 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|